• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地塞米松能否抑制盘尾丝虫病患者的马佐蒂反应?

Does dexamethasone suppress the Mazzotti reaction in patients with onchocerciasis?

作者信息

Stingl P, Pierce P F, Connor D H, Gibson D W, Straessle T, Ross M A, Ribas J L

机构信息

National Leprosy Training Centre, Wau, Southern Sudan.

出版信息

Acta Trop. 1988 Mar;45(1):77-85.

PMID:2896449
Abstract

The Mazzotti reaction is a frequent complication in patients with onchocerciasis being treated with diethylcarbamazine (DEC); and more severe manifestations of this reaction may be unacceptable in many patients. It has recently been demonstrated that prednisone modifies the severity of this reaction and reduces the microfilaricidal activity of DEC. A clinical trial was performed at the National Leprosy Training Center in Wau, Sudan, to evaluate the clinical and histologic effect of the use of corticosteroids in patients receiving DEC. Administration of a low dose of dexamethasone (3 mg/day), begun after onset of the Mazzotti reaction, modifies the progression of the Mazzotti reaction without interfering with the microfilaricidal efficacy of DEC. Pretreatment with low-dose dexamethasone--prior to beginning DEC therapy--prevents the development of the Mazzotti reaction and greatly reduces the microfilaricidal activity. Administration of diphenhydramine, after onset of the Mazzotti reaction, has no effect on the course and intensity of the Mazzotti reaction nor on microfilaricidal activity. We recommend that low-dose corticosteroids be administered in conjunction with DEC--after onset of the Mazzotti reaction--and that they be tapered rapidly.

摘要

马佐蒂反应是接受乙胺嗪(DEC)治疗的盘尾丝虫病患者常见的并发症;这种反应的更严重表现对许多患者来说可能是不可接受的。最近有研究表明,泼尼松可减轻该反应的严重程度,并降低DEC的杀微丝蚴活性。在苏丹瓦乌的国家麻风病培训中心进行了一项临床试验,以评估在接受DEC治疗的患者中使用皮质类固醇的临床和组织学效果。在马佐蒂反应开始后开始给予低剂量地塞米松(3毫克/天),可改变马佐蒂反应的进程,而不影响DEC的杀微丝蚴疗效。在开始DEC治疗前用低剂量地塞米松预处理可预防马佐蒂反应的发生,并大大降低杀微丝蚴活性。在马佐蒂反应开始后给予苯海拉明,对马佐蒂反应的进程和强度以及杀微丝蚴活性均无影响。我们建议在马佐蒂反应开始后,将低剂量皮质类固醇与DEC联合使用,并迅速减量。

相似文献

1
Does dexamethasone suppress the Mazzotti reaction in patients with onchocerciasis?地塞米松能否抑制盘尾丝虫病患者的马佐蒂反应?
Acta Trop. 1988 Mar;45(1):77-85.
2
[Cutaneous changes induced by a dose of DEC in rodents with skin microfilaria: relevance of these phenomena for understanding the Mazzotti reaction and the pathogenesis of human onchocerciasis].[乙胺嗪剂量对患有皮肤微丝蚴的啮齿动物皮肤变化的影响:这些现象对于理解马佐蒂反应和人类盘尾丝虫病发病机制的相关性]
C R Acad Sci III. 1987;304(6):133-8.
3
Leprosy, onchocerciasis, diethylcarbamazine and the Mazzotti reaction.麻风病、盘尾丝虫病、乙胺嗪与马佐蒂反应。
Lepr Rev. 1982 Dec;53(4):317-8.
4
Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis.嗜酸性粒细胞脱颗粒。人类盘尾丝虫病中马佐蒂反应发病机制中的一种免疫决定因素。
J Immunol. 1990 May 15;144(10):3961-9.
5
The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity.用乙胺嗪治疗盘尾丝虫病后的马佐蒂反应:临床严重程度与感染强度的关系。
Am J Trop Med Hyg. 1985 May;34(3):529-36. doi: 10.4269/ajtmh.1985.34.529.
6
Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.高剂量乙胺嗪或单剂量伊维菌素治疗盘尾丝虫病:微丝蚴水平及副作用
Trop Med Parasitol. 1988 Mar;39(1):19-24.
7
A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.在一项针对塞内加尔盘尾丝虫病患者的安慰剂对照研究中,伊维菌素和乙胺嗪疗效与安全性的双盲比较。
Trans R Soc Trop Med Hyg. 1986;80(6):927-34. doi: 10.1016/0035-9203(86)90262-2.
8
Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.通过皮肤接触乙胺嗪诊断盘尾丝虫感染:基于透皮给药技术的贴片的临床评估
Parasit Vectors. 2015 Oct 9;8:515. doi: 10.1186/s13071-015-1122-9.
9
Long-term treatment of onchocerciasis patients from the Liberian rain-forest with low doses of diethylcarbamazine citrate after complete nodulectomy.在完全切除结节后,用低剂量枸橼酸乙胺嗪对来自利比里亚雨林地区的盘尾丝虫病患者进行长期治疗。
Tropenmed Parasitol. 1983 Dec;34(4):267-70.
10
The Onchocerca volvulus micro- and macrofilarial responses in onchocerciasis patients to increased dosage of diethylcarbamazine.盘尾丝虫病患者体内盘尾丝虫微丝蚴和成虫对乙胺嗪剂量增加的反应
Trop Med Parasitol. 1985 Sep;36(3):175-9.

引用本文的文献

1
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.一项随机、安慰剂对照、双盲的初步研究,评估单次给予人源化抗 IL-5 抗体(瑞利珠单抗)对依氟鸟氨酸治疗罗阿丝虫感染后嗜酸性粒细胞增多的影响。
Clin Infect Dis. 2021 Oct 5;73(7):e1624-e1631. doi: 10.1093/cid/ciaa1365.
2
Infection-associated Immune Perturbations Resolve 1 Year Following Treatment for Loa loa.感染相关的免疫紊乱在治疗罗阿罗阿后 1 年得到解决。
Clin Infect Dis. 2021 Mar 1;72(5):789-796. doi: 10.1093/cid/ciaa137.
3
Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.
喀麦隆大规模伊维菌素治疗盘尾丝虫病相关罗阿丝虫严重不良事件的临床表现、流行病学及结局
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S4. doi: 10.1186/1475-2883-2-S1-S4.